Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Multiple Assemblies exist for SMTL entry 3f5x
CDK-2-Cyclin complex with indazole inhibitor 9 bound at its active site; X-RAY DIFFRACTION 2.40 Å

SMTL ID
3f5x.1
Ligands
GLYCEROL; 4-{3-[7-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-indazol-6-yl}aniline; SULFATE ION
Polypeptides
Cell division protein kinase 2; Cyclin-A2
Oligo-state
hetero-4-4-mer
SMTL ID
3f5x.2
Ligands
GLYCEROL; 4-{3-[7-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-indazol-6-yl}aniline; SULFATE ION
Polypeptides
Cell division protein kinase 2; Cyclin-A2
Oligo-state
hetero-2-2-mer
SMTL ID
3f5x.3
Ligands
GLYCEROL; 4-{3-[7-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-indazol-6-yl}aniline
Polypeptides
Cell division protein kinase 2; Cyclin-A2
Oligo-state
hetero-1-1-mer
SMTL ID
3f5x.4
Ligands
GLYCEROL; 4-{3-[7-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-indazol-6-yl}aniline; SULFATE ION
Polypeptides
Cell division protein kinase 2; Cyclin-A2
Oligo-state
hetero-1-1-mer